explored the prognostic value of PPFIA1 alone or in combination with TMEM16A and FADD in patients with invasive breast cancer and found that combined expression was significantly associated with perineural invasion and a low disease-free survival rate. This evidence concerns the gene PPFIA1 and invasive breast carcinoma.